Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo
Weight loss accelerates in weeks 2-8 as your appetite regulation stabilizes
GLP-1 pathways interact with regions of the brain involved with focus, mood, and cognitive health, which may support clearer thinking and more consistent mental energy
Taken for less than 1 month September 13, 2022 For Type 2 Diabetes "I usually dont share reviews but felt this was warranted
US$ 29.55
US$ 20.88
US$ 26.88
US$ 22.13
US$ 28.57
